PRINCIPLE: a community-based COVID-19 platform trial
Lancet Respir Med
.
2021 Sep;9(9):943-945.
doi: 10.1016/S2213-2600(21)00360-X.
Epub 2021 Jul 28.
Authors
John Macleod
1
,
John Norrie
2
Affiliations
1
Centre for Academic Primary Care, University of Bristol, Bristol UK. Electronic address: john.macleod@bristol.ac.uk.
2
Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
PMID:
34331866
PMCID:
PMC8318404
DOI:
10.1016/S2213-2600(21)00360-X
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Antiviral Agents / therapeutic use
COVID-19*
Humans
Research
SARS-CoV-2
Substances
Antiviral Agents